Vetsys Pharmaceutical
Vetsys Pharmaceutical
Established Year
Registered Capital (RMB)
Annual Sales (USD)
Specialized Labs
Leading Chinese exporters utilize Molecular Distillation and Supercritical CO2 Extraction. These methods allow for the concentration of EPA and DHA to levels exceeding 90% purity while removing environmental contaminants like PCBs and dioxins.
By integrating logistics with large-scale processing hubs, China-based exporters like Vetsys offer a significant Information Gain in cost-efficiency without compromising the GMP (Good Manufacturing Practice) standards essential for pharmaceutical applications.
Navigating the regulatory landscape of the FDA (USA), EFSA (Europe), and TGA (Australia) is a hallmark of top-tier exporters. Vetsys ensures that every batch meets international pharmacopeia standards (USP/EP).
Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) is not merely a manufacturer; it is a pioneer in the animal pharmaceutical industry. With a robust foundation built on 30 million RMB of registered capital, our facility is a marvel of modern engineering, housing specialized workshops for powders, premixes, injections, and herbal drug extracts.
Our commitment to Technological Innovation and Research is evidenced by our independent research institute. By employing a team of world-class scientists and maintaining five specialized laboratories, we bridge the gap between "standard supply" and "precision formulation." This scientific rigor is exactly what the global Omega fatty acid market requires—stability, bioavailability, and clinical efficacy.
Mold Injection
Welding
Assembly
Packaging
Adapting EPA/DHA ratios for specific regional needs—such as high-EPA formulas for inflammatory conditions in cold climates or high-DHA for prenatal animal nutrition.
Providing full CTD (Common Technical Document) dossiers for faster product registration in target markets.
Meeting the increasing demand for Algal Oil (Vegan Omega-3) as a sustainable alternative to traditional fish oil, appealing to the eco-conscious European and North American markets.
Vetsys utilizes strategic partnerships to offer cold-chain logistics, ensuring that the oxidation-sensitive fatty acids remain potent from the factory to the end-user.
Our production lines are a testament to the "Smart Factory" concept, integrating various molding and processing technologies to ensure complete vertical integration.
Injection Molding
Blow Molding
Extrusion Molding
Processing
Drying
Assembly
Final Packing & Quality Inspection
Key indicators include GMP certification, R&D capabilities, annual export volume, TOTOX value control (purity), and the ability to provide comprehensive regulatory support for different global regions.
Omega fatty acids are highly prone to oxidation, which leads to rancidity and loss of efficacy. Top exporters use nitrogen blanketing and advanced antioxidants (like mixed tocopherols) to ensure a shelf life of up to 24 months.
We adhere to strict GMP standards, overseen by a comprehensive quality management system. Each batch undergoes extensive QC checks in our five specialized laboratories before market release.
Yes, through our advanced R&D institute and versatile production lines (granules, oral liquids, tablets), we offer full-service OEM/ODM solutions tailored to specific market demands.
The industry is shifting towards plant-based Algal Oil (DHA), higher concentration ethyl esters (EE), and re-esterified triglycerides (rTG) for better bioavailability, alongside a massive push for fully traceable supply chains.
